Systemic cytotoxic therapy of basal cell carcinoma

@inproceedings{Pfeiffer1990SystemicCT,
  title={Systemic cytotoxic therapy of basal cell carcinoma},
  author={Per Pfeiffer and Olfred Hansen and Carsten Rose},
  year={1990}
}
Abstract Fifty-five cases of systemic, cytotoxic therapy of patients with basal cell carcinoma have been reported in 53 patients in the English literature since the first report in 1960 . Cytotoxic therapy without cis -platinum was used in 28 cases, resulting in only one partial response. On the contrary, 17 out of 22 evaluable patients ( 77% ) responded to systemic treatment with cis -platinum-containing regimens. In 10 patients ( 45% ) complete disappearance of the tumor was noted. These… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Concepts, Mechanisms, and New Targets for Chemotherapy

  • Cancer Treatment and Research
  • 1995
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Basal Cell Carcinoma.

  • Proceedings of the Royal Society of Medicine
  • 2018

Basal Cell Carcinoma Metastatic to Parotid Gland

  • Head and Neck Pathology
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND